Skip to Main Content

Paper Details

High-content CRISPR screening.
Nat Rev Methods Primers
124
2022
CRISPR, cancer, genes, guide RNAs, infectious diseases, screened cells, single, target genes, targeted cells
Author NameAffiliation
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockInstitute of Artificial Intelligence, Center for Medical Statistics, Medical University of Vienna
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Christoph BockInstitute of Artificial Intelligence, Center for Medical Statistics, Medical University of Vienna
Paul DatlingerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Jason MoffatUniversity of Toronto
Jason MoffatUniversity of Toronto
Jason MoffatInstitute for Biomaterials and Biomedical Engineering, University of Toronto
Lei S QiStanford University
Lei S QiStanford University
Lei S QiStanford University
Jay ShendureUniversity of Washington
Jay ShendureHoward Hughes Medical Institute, University of Washington
Jay ShendureBrotman Baty Institute for Precision Medicine
Jay ShendureUniversity of Washington
Jay ShendureBrotman Baty Institute for Precision Medicine
Jay ShendureHoward Hughes Medical Institute, University of Washington
Xiaowei ZhuangHoward Hughes Medical Institute, Harvard University
Xiaowei ZhuangHarvard University
Xiaowei ZhuangHarvard University
  • 1 - 20

Datasets